Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Classification of Mutation Characteristics by Whole-Exome Sequencing (WES) in Intraductal Neoplasms of the Bile Duct (IPNB) Patients

NCT03838913 is registered in ClinicalTrials.gov with Fujian Provincial Hospital as lead sponsor.

NCT NCT03838913
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03838913 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Classification of Mutation Characteristics by Whole-Exome Sequencing (WES) in Intraductal Neoplasms of the Bile Duct (IPNB) Patients
Lead sponsor
Fujian Provincial Hospital
Phase
Observational
Overall status
Unknown status
Start date
February 15, 2019
Completion date
December 31, 2019
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bile duct neoplasms, intraductal papillary mucinous neoplasm